• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18β-甘草次酸与伏立诺他的缀合物可降解 HDAC3 和 HDAC6,并具有改善的抗肿瘤作用。

A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects.

机构信息

Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.

出版信息

Eur J Med Chem. 2020 Feb 15;188:111991. doi: 10.1016/j.ejmech.2019.111991. Epub 2019 Dec 20.

DOI:10.1016/j.ejmech.2019.111991
PMID:31883490
Abstract

Semisynthetic 18β-glycyrrhetinic acid (GA) analogues bearing 1-en-2-cyano-3-oxo substitution on ring A have enhanced antitumor effects with reduced levels of HDAC3 and HDAC6 proteins. Aiming to inhibit both HDAC protein and activity, we developed a hybrid molecule by tethering active GA analogue methyl 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate (CDODA-Me) and Vorinostat (SAHA). We tested the proper hybrid approaches of GA with hydroxamic acid and turned out that GA conjugated with SAHA by a piperazine linker was the best. The conjugate (15) of CDODA-Me and SAHA linked through a piperazine group was a potent cytotoxic agent against cancer cells with apoptosis induction. Compound 15 was more effective than the simple combination of CDODA-Me and SAHA to induce apoptosis. Mechanistic studies revealed that 15 was less effective than SAHA to inhibit HDAC activity, but was more effective than CDODA-Me to decrease the levels of HDAC3 and HDAC6 proteins with upregulated levels of acetylated H3 and acetylated α-tubulin. Compound 15 represents a new HDAC3 and HDAC6 inhibitor by reducing protein levels.

摘要

具有 A 环 1-烯-2-氰基-3-氧取代的半合成 18β-甘草次酸(GA)类似物具有增强的抗肿瘤作用,同时降低 HDAC3 和 HDAC6 蛋白水平。为了抑制 HDAC 蛋白和活性,我们通过连接活性 GA 类似物甲基 2-氰基-3,11-二氧代-18β-齐墩果-1,12-二烯-30-酸酯(CDODA-Me)和伏立诺他(SAHA)开发了一种杂合分子。我们测试了 GA 与羟肟酸的合适杂合方法,结果表明,通过哌嗪连接子将 GA 与 SAHA 连接的缀合物是最好的。通过哌嗪基团连接的 CDODA-Me 和 SAHA 的缀合物(15)是一种有效的细胞毒性剂,可诱导癌细胞凋亡。与 CDODA-Me 和 SAHA 的简单组合相比,化合物 15 更有效地诱导细胞凋亡。机制研究表明,与 SAHA 相比,15 抑制 HDAC 活性的效果较差,但与 CDODA-Me 相比,它降低 HDAC3 和 HDAC6 蛋白水平的效果更好,同时乙酰化 H3 和乙酰化α-微管蛋白水平升高。化合物 15 通过降低蛋白水平代表了一种新的 HDAC3 和 HDAC6 抑制剂。

相似文献

1
A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects.18β-甘草次酸与伏立诺他的缀合物可降解 HDAC3 和 HDAC6,并具有改善的抗肿瘤作用。
Eur J Med Chem. 2020 Feb 15;188:111991. doi: 10.1016/j.ejmech.2019.111991. Epub 2019 Dec 20.
2
Synthesis and antitumor effects of novel 18β-glycyrrhetinic acid derivatives featuring an exocyclic α,β-unsaturated carbonyl moiety in ring A.新型 18β-甘草次酸衍生物的合成及体外抗肿瘤活性研究,此类衍生物在 A 环上具有一个环状的α,β-不饱和羰基。
Bioorg Chem. 2020 Oct;103:104187. doi: 10.1016/j.bioorg.2020.104187. Epub 2020 Aug 26.
3
HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogue.HDAC 和 Ku70 轴 - 新型 2-氰基-3-氧代-1,9-二烯甘草次酸类似物诱导细胞凋亡的有效靶点。
Cell Death Dis. 2018 May 24;9(6):623. doi: 10.1038/s41419-018-0602-1.
4
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.甘草次酸衍生物作为结肠癌细胞中过氧化物酶体增殖物激活受体γ激动剂的结构依赖性活性
Mol Cancer Ther. 2007 May;6(5):1588-98. doi: 10.1158/1535-7163.MCT-07-0022.
5
Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.2-氰基-3,11-二氧代-18β-齐墩果-1,12-二烯-30-甲酯是一种过氧化物酶体增殖物激活受体γ激动剂,可诱导LNCaP前列腺癌细胞发生非受体依赖性凋亡。
Mol Pharmacol. 2008 Feb;73(2):553-65. doi: 10.1124/mol.107.041285. Epub 2007 Nov 7.
6
Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.致癌性微小RNA-27a是结肠癌细胞中抗癌剂2-氰基-3,11-二氧代-18β-齐墩果-1,12-二烯-30-酸甲酯的作用靶点。
Int J Cancer. 2009 Oct 15;125(8):1965-74. doi: 10.1002/ijc.24530.
7
Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor.甲基 2-氰基-3,11-二氧代-18-齐墩果-1,12-二烯-30-酸酯(CDODA-Me)是甘草次酸的衍生物,具有很强的血管生成抑制作用。
J Pharmacol Exp Ther. 2010 Oct;335(1):172-9. doi: 10.1124/jpet.110.171066. Epub 2010 Jul 14.
8
The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.组蛋白去乙酰化酶抑制剂的结构要求:C4修饰的SAHA类似物具有HDAC6/HDAC8双重选择性。
Eur J Med Chem. 2018 Jan 1;143:1790-1806. doi: 10.1016/j.ejmech.2017.10.076. Epub 2017 Oct 31.
9
Synthesis of methyl 2-cyano-3,12-dioxo-18β-olean-1,9(11)-dien-30-oate analogues to determine the active groups for inhibiting cell growth and inducing apoptosis in leukemia cells.合成2-氰基-3,12-二氧代-18β-齐墩果-1,9(11)-二烯-30-酸甲酯类似物,以确定抑制白血病细胞生长和诱导其凋亡的活性基团。
Org Biomol Chem. 2014 Sep 14;12(34):6706-16. doi: 10.1039/c4ob00703d.
10
CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species.CDODA-Me可降低特异性蛋白转录因子水平,并通过诱导活性氧来诱导膀胱癌细胞凋亡。
Urol Oncol. 2016 Aug;34(8):337.e11-8. doi: 10.1016/j.urolonc.2016.02.025. Epub 2016 Mar 30.

引用本文的文献

1
Epigenetics-targeted drugs: current paradigms and future challenges.表观遗传学靶向药物:当前范例与未来挑战。
Signal Transduct Target Ther. 2024 Nov 26;9(1):332. doi: 10.1038/s41392-024-02039-0.
2
Application of 18β-glycyrrhetinic acid in the structural modification of natural products: a review.18β-甘草次酸在天然产物结构修饰中的应用:综述
Mol Divers. 2025 Feb;29(1):739-781. doi: 10.1007/s11030-024-10864-2. Epub 2024 Apr 29.
3
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies.
基于PROTAC、分子胶和疏水标签技术的表观遗传降解剂概述。
Acta Pharm Sin B. 2024 Feb;14(2):533-578. doi: 10.1016/j.apsb.2023.09.003. Epub 2023 Sep 12.
4
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer.组蛋白去乙酰化酶6在癌症双靶点治疗中的靶向作用
Pharmaceutics. 2023 Nov 3;15(11):2581. doi: 10.3390/pharmaceutics15112581.
5
In Silico Prediction of Steroids and Triterpenoids as Potential Regulators of Lipid Metabolism.计算机预测甾体和三萜类化合物作为潜在的脂代谢调节剂。
Mar Drugs. 2021 Nov 22;19(11):650. doi: 10.3390/md19110650.
6
Angioedema and Fatty Acids.血管性水肿与脂肪酸。
Int J Mol Sci. 2021 Aug 20;22(16):9000. doi: 10.3390/ijms22169000.
7
Piperazine skeleton in the structural modification of natural products: a review.哌嗪骨架在天然产物结构修饰中的应用:综述。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1165-1197. doi: 10.1080/14756366.2021.1931861.
8
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs.发现组蛋白去乙酰化酶 3(HDAC3)特异性 PROTAC 分子。
Chem Commun (Camb). 2020 Aug 25;56(68):9866-9869. doi: 10.1039/d0cc03243c.